Clinical trial experiences with Physioneal™

Kidney International, Supplement

Volumn 64, Issue 88, 2003, Pages

  Pecoits Filho, Roberto ^b   Tranaeus, Anders ^b   Lindholm, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

Lactate; Peritoneal dialysis; Physioneal

Indexed keywords

BICARBONATE; DIALYSIS FLUID; LACTIC ACID; PHYSIONEAL FLUID; UNCLASSIFIED DRUG; DENTIN BONDING AGENT; LACTIC ACID DERIVATIVE; XENO III;

BICARBONATE BLOOD LEVEL; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; GENERAL CONDITION IMPROVEMENT; HUMAN; LACTIC ACIDOSIS; PAIN ASSESSMENT; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULTRAFILTRATION; ACID BASE BALANCE; ANTIBODY PRODUCTION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HOMEOSTASIS; IMMUNOLOGY; INFECTION; PAIN; RANDOMIZED CONTROLLED TRIAL;

ACID-BASE EQUILIBRIUM; ANTIBODY FORMATION; BICARBONATES; DENTIN-BONDING AGENTS; DIALYSIS SOLUTIONS; HOMEOSTASIS; HUMANS; INFECTION; LACTATES; PAIN; RANDOMIZED CONTROLLED TRIALS; ULTRAFILTRATION;

EID: 0345305342     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.08811.x     Document Type: Review

References (24)

1. BEROSSTROM J: Metabolic acidosis and nutrition in dialysis patients. Blood Purif 13:361-367, 1995
2. GRAHAM KA, REAICH D, CHANNON SM, et al: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632-637, 1997
3. GRAHAM KA, HOENICH NA, GOODSHIP TH: Pre and interdialytic acid-base balance in hemodialysis patients. Int J Artif Organs 24:192-196, 2001
4. HUTCHISON AJ, GOKAL R: Improved solutions for peritoneal dialysis: Physiological calcium solutions, osmotic agents and buffers. Kidney Int 38(Suppl):S153-159, 1992
5. SLINGENEYER A, MION C, MOURAD G, et al: Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 29:633-640, 1983
6. MACTIER RA, SPROSEN TS, GOKAL R, et al: Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 53:1061-1067, 1998
7. TOPLEY N: In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int 17:42-47, 1997
8. CANCARINI GC, FAICT D, DE Vos C, et al: Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate. Perit Dial Int 18:576-582, 1998
9. COLES GA, GOKAL R, OGG C, et al: A randomized controlled trial of a bicarbonate-and a bicarbonate/lactate-containing dialysis solution in CAPD. Perit Dial Int 17:48-51, 1997
10. COLES GA, O'DONOGHUE DJ, PRITCHARD N, et al: A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - Final report. Nephrol Dial Transplant 13:3165-3171, 1998
11. MACKENZIE RK, HOLMES CJ, MOSELEY A, et al: Bicarbonate/lactate-and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNF-α secretion. J Am Soc Nephrol 9:1499-1506, 1998
12. TOPLEY N, KAUR D, PETERSEN MM, et al: In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 7:218-224, 1996
13. STEIN A, MOORHOUSE J, ILES-SMITH H, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089-1095, 1997
14. WALLS J: Metabolic acidosis and uremia. Perit Dial Int 15:S36-38, 1995
15. OTTE K, GONZALEZ MT, BAJO MA, et al: Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 23:138-145, 2003
16. TRANAEUS A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - Clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20:516-523, 2000
17. CARRASCO AM, RUBIO MA, SANCHEZ TOMMERO JA, et al: Acidosis correction with a new 25 mmol/l bicarbonate/15 mmol/l lactate peritoneal dialysis solution. Perit Dial Int 21:546-553, 2001
18. BUNCHMAN TE, BALLAL SH: Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis. Perit Dial Int 11:179-180, 1991
19. YAMAMOTO T, SAKAKURA T, YAMAKAWA M, et al: Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 60:324-329, 1992
20. WILLIAMS P, MARIOTT J, COLES G, et al: Insulin efficacy with a new bicarbonate/lactate peritoneal dialysis solution. Perit Dial Int 20:467-469, 2000
21. MACKENZIE RK, JONES S, MOSELEY A, et al: In vivo exposure to bicarbonate/lactate-and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function. Am J Kidney Dis 35:112-121, 2000
22. COOKER LA, LUNEBURG P, HOLMES CJ, et al: Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions. Perit Dial Int 21(Suppl 3):S102-107, 2001
23. JONES S, HOLMES CJ, KREDIET RT, et al: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59:1529-1538, 2001
24. PECOITS-FILHO R, BARANY P, LINDHOLM B. et al: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688, 2002